Contract drug developer ABL acquired a French production facility from biotech Transgene, buying its way into Europe with a plant that specializes in treatments using viral vectors. More
> IT firm Aurotech launched software it said can help CROs and drugmakers manage the development process. Item
> Patheon recruited an Amgen ($AMGN) veteran to lead its biologics business. News